iLAB 100 - Company finances
|
EUR
|
2021
From: 2021-04-23
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | - | 34,726 | 26,372 | 36,126 | 61,221 |
| Profit before tax | - | - | - | - | - |
| Net profit | 0 | 4,751 | -14,552 | -19,998 | 10,126 |
| Equity | 2,500 | 7,251 | -7,301 | -27,298 | -17,173 |
| Liabilities | 0 | 26,993 | 35,002 | 48,085 | 49,577 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 |
| Current assets | 2,500 | 34,244 | 27,701 | 20,787 | 32,404 |
| Total assets | 2,500 | 34,244 | 27,701 | 20,787 | 32,404 |
|
Taxes paid
|
|||||
| STI taxes | - | - | 8,157 | 9,138 | 11,205 |
|
Financial indicators
|
|||||
| Revenue change y/y | - | - | -24.1% | +37.0% | +69.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | 13.9% | -52.5% | -96.2% | 31.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | 65.5% | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | 13.7% | -55.2% | -55.4% | 16.5% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 3.7 | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 20,835 | 13,186 | 18,063 | 30,611 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
iLAB 100 - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-10-07 | 2026-10-08 | 3.76 |
| 2026-10-03 | 2026-10-05 | 3.76 |
| 2026-09-26 | 2026-09-28 | 3.76 |
| 2026-09-20 | 2026-09-21 | 246.31 |
| 2026-09-16 | 2026-09-17 | 246.31 |
| 2026-07-23 | 2026-07-26 | 3.76 |
| 2026-07-19 | 2026-07-19 | 246.31 |
| 2026-07-16 | 2026-07-17 | 246.31 |
| 2026-06-16 | 2026-06-24 | 258.62 |
| 2026-05-17 | 2026-05-25 | 492.62 |
| 2026-04-27 | 2026-04-27 | 494.03 |
| 2026-04-26 | 2026-04-26 | 492.62 |
| 2026-04-24 | 2026-04-25 | 494.03 |
| 2026-04-20 | 2026-04-23 | 492.62 |
| 2026-03-17 | 2026-03-27 | 492.62 |
| 2026-01-22 | 2026-01-28 | 10.64 |
| 2025-12-18 | 2025-12-30 | 735.52 |
| 2025-12-16 | 2025-12-17 | 730.14 |
| 2025-11-18 | 2025-12-03 | 730.14 |
| 2025-10-16 | 2025-11-06 | 730.14 |
| 2025-09-16 | 2025-10-08 | 730.14 |
| 2025-08-28 | 2025-08-29 | 457.26 |
| 2025-08-19 | 2025-08-24 | 457.26 |
| 2025-02-18 | 2025-02-18 | 155.79 |
| 2024-10-16 | 2024-10-20 | 65.67 |
| 2023-09-28 | 2023-10-09 | 46.57 |
| 2023-09-18 | 2023-09-27 | 178.67 |
| 2023-08-17 | 2023-08-22 | 178.67 |
| 2023-03-16 | 2023-04-11 | 0.19 |
| 2023-02-17 | 2023-03-12 | 0.19 |
| 2023-02-06 | 2023-02-06 | 0.19 |
| 2023-01-24 | 2023-02-03 | 0.19 |
| 2022-11-17 | 2022-11-18 | 103.51 |
iLAB 100 - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-09-04 | 2026-09-23 | 8.35 |
| 2026-09-01 | 2026-09-03 | 212.19 |
| 2026-08-31 | 2026-08-31 | 2827.41 |
| 2026-08-28 | 2026-08-30 | 2825.85 |
| 2026-08-19 | 2026-08-27 | 203.85 |
| 2026-07-02 | 2026-07-07 | 23.15 |
| 2026-06-30 | 2026-07-01 | 431.45 |
| 2026-06-27 | 2026-06-29 | 412.99 |
| 2026-06-03 | 2026-06-26 | 6.0 |
| 2026-06-01 | 2026-06-02 | 5542.71 |
| 2026-05-31 | 2026-05-31 | 5533.89 |
| 2026-05-28 | 2026-05-30 | 5534.14 |
| 2026-05-26 | 2026-05-27 | 1832.14 |
| 2026-05-22 | 2026-05-25 | 1771.08 |
| 2025-07-31 | 2025-07-31 | 2182.68 |
| 2025-07-28 | 2025-07-30 | 2182.42 |
| 2025-03-28 | 2025-03-31 | 442.77 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
iLAB 100, UAB (Private Limited Liability Company, code 305741166) operates in the wholesale of perfume and cosmetics. In 2025, the latest financial year, the company generated revenue of EUR 61.2K, up 69.5% year on year and 132.1% over two years. This growth also marked a turnaround in profitability: net profit reached EUR 10.1K in 2025 after losses of EUR 14.6K in 2023 and EUR 20.0K in 2024. The 2025 profit margin was 16.5%, compared with negative margins in the two previous years. The balance sheet remains pressured, however, with total assets of EUR 32.4K, liabilities of EUR 49.6K and negative equity of EUR 17.2K. Assets increased from EUR 20.8K in 2024, while liabilities stayed broadly stable. Return measures should be read cautiously given the negative equity base, but the latest year shows improved operating performance. Revenue per employee was EUR 30.6K and profit per employee EUR 5.1K, indicating moderate productivity relative to the company’s scale.